Differential expression and processing of chromogranin A and secretogranin II in relation to the secretory status of endocrine cells.
Chromogranin A (CgA) and secretogranin II (SgII) are neuroendocrine secretory proteins that participate in regulation of the secretory pathway and also serve as precursors of biologically active peptides. To investigate whether there is a relationship between the expression, distribution, and processing of CgA and SgII and the degree of secretory activity, we employed two melanotrope subpopulations of the pituitary intermediate lobe that exhibit opposite secretory phenotypes. Thus, although one of the melanotrope subtypes shows high secretory activity, the other exhibits characteristics of a hormone storage phenotype. Our data show that SgII expression levels were higher in secretory melanotropes, whereas CgA expression showed similar rates in both cell subsets. The use of various antibodies revealed the presence of the unprocessed proteins as well as three CgA-derived peptides (67, 45, and 30 kDa) and six SgII-derived peptides (81, 66, 55, 37, 32, and 30 kDa) in both subpopulations. However, the smallest molecular forms of both granins predominated in secretory melanotropes, whereas the largest SgII- and CgA-immunoreactive peptides were more abundant in storage melanotropes, which is suggestive of a more extensive processing of granins in the secretory subset. Confocal microscopy studies showed that CgA immunoreactivity was higher in storage cells, but SgII immunoreactivity was higher in secretory melanotropes. Taken together, our results indicate that SgII and CgA are differentially regulated in melanotrope subpopulations. Thus, SgII expression is strongly related to the secretory activity of melanotrope cells, whereas CgA expression may not be related to secretory rate, but, rather, to hormone storage in this endocrine cell type.
Peinado
J R
JR
Department of Cell Biology, Physiology, and Immunology, Campus de Rabanales. Edificio Severo Ochoa, Planta 3, University of Cordoba, E-14014 Cordoba, Spain.
Vazquez-Martinez
R
R
Cruz-García
D
D
Ruiz-Navarro
A
A
Anouar
Y
Y
Tonon
M C
MC
Vaudry
H
H
Gracia-Navarro
F
F
Castano
J P
JP
Malagón
M M
MM
D000818:Animals; D015153:Blotting, Western; D053379:Chromogranin A; D002864:Chromogranins / Q000096:biosynthesis* / Q000737:chemistry / Q000378:metabolism; D003720:Densitometry; D004703:Endocrine System / Q000166:cytology / Q000378:metabolism*; D015870:Gene Expression; D005786:Gene Expression Regulation; D006801:Humans; D007150:Immunohistochemistry; D018613:Microscopy, Confocal; D015233:Models, Statistical; D010455:Peptides / Q000737:chemistry; D010641:Phenotype; D010902:Pituitary Gland / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D011898:Ranidae; D020133:Reverse Transcriptase Polymerase Chain Reaction
C506150:CHGA protein, human; D053379:Chromogranin A; D002864:Chromogranins; D010455:Peptides; D012333:RNA, Messenger; D012313:RNA